Picture of Ovoca Bio logo

OVB Ovoca Bio News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

REG - Ovoca Bio PLC - Delisting from Euronext Growth Exchange

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250605:nRSE4791La&default-theme=true

RNS Number : 4791L  Ovoca Bio PLC  05 June 2025

 

Ovoca Bio PLC

5 June 2025

 

 

Ovoca Bio plc

("Ovoca" or the "Company")

 

Delisting from Euronext Growth Exchange

 

 

 

Further to the Company's press release of 7 May 2025, Ovoca confirms that the
admission of Ovoca Ordinary Shares to trading on Euronext Growth was cancelled
with effect from 7.00 am today, 5 June 2025 (the "Cancellation"). The Company
will remain listed on the AIM Market of the London Stock Exchange, although
presently share trading is suspended and has been since May 7, 2025.

 

As previously stated, the Cancellation was agreed to by the Board of the
Company to consolidate trading of the Company's ordinary shares to the AIM
Market, where the majority of the trading liquidity in the Company's ordinary
shares is located. The Cancellation will also remove certain costs,
complexities and duplication that comes from administering two listing regimes
and will have no impact on Ovoca's Ordinary Shares which will continue to be
admitted to AIM.

 

 

 

End

 

For further information:

 

Ovoca Bio plc

Timothy McCutcheon (Chief Executive Officer)

Tel +353 1 661 9819

info@ovocabio.com (mailto:info@ovocabio.com)

 

Beaumont Cornish Limited (Nominated Adviser and Broker)

James Biddle/ Roland Cornish

Tel: +44 (0) 207 628 3396

 

Davy (Euronext Growth Listing Sponsor)

Ivan Murphy / Daragh O'Reilly

Tel: +353 1 679 6363

 

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated
Adviser and is authorised and regulated by the FCA. Beaumont Cornish's
responsibilities as the Company's Nominated Adviser, including a
responsibility to advise and guide the Company on its responsibilities under
the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed
solely to the London Stock Exchange. Beaumont Cornish is not acting for and
will not be responsible to any other persons for providing protections
afforded to customers of Beaumont Cornish nor for advising them in relation to
the proposed arrangements described in this announcement or any matter
referred to in it.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSSEFILEISEDM

Recent news on Ovoca Bio

See all news